October 19, 2019

October 18, 2019

Subscribe to Latest Legal News and Analysis

October 17, 2019

Subscribe to Latest Legal News and Analysis

UPM Biofuels Receives First RSB Low ILUC Risk Certification

On April 24, 2018, UPM Biofuels announced that its crude tall oil (CTO) feedstock for BioVerno renewable fuels had received the first ever RSB (Roundtable of Sustainable Biomaterials) low ILUC (indirect land use change) risk certification. This certificate confirms that the amount of CTO used to make BioVerno is sustainable and not diverted from other uses, resulting in little to no ILUC risk. Rolf Hogan, Executive Director of RSB, said of the certification:

The RSB is proud to count UPM among the visionary biofuel producers that are not only RSB certified for their wood-based biofuels in Lappeenranta, Finland and Brassica carinata cultivation in Uruguay, but have now received the world's first RSB low ILUC risk certification. This shows that their biofuels have not only achieved the requirements of our rigorous standard for sustainability, they have also been verified under this module, meaning they have minimal or zero risk of indirect impacts - such as deforestation or increased food prices - elsewhere in the world. With reduced greenhouse gas emissions which meet the highest standards of sustainability and transparency, as well as demonstrating the lowest impacts on nature and food production, these are the biofuels of the future.

©2019 Bergeson & Campbell, P.C.

TRENDING LEGAL ANALYSIS


About this Author

Lynn Bergeson, Campbell PC, Toxic Substances Control Act Attorney, federal insecticide lawyer, industrial biotechnology legal counsel, Food Drug Administration law
Managing Partner

Owner of Bergeson & Campbell, P.C. (B&C®), Lynn L. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), European Union Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and especially how these regulatory programs pertain to nanotechnology, industrial biotechnology, synthetic biology, and other emerging transformative technologies. Her knowledge of and involvement in the policy...

202-557-3801